Ryan Huey, Deputy Division Head of Clinical Quality and Effectiveness, Division of Cancer Medicine at UT MD Anderson shared on LinkedIn:
“Proud of Dr. Victoria Higbie and the work she has led with DPYD testing for patients prior to receipt of 5-Fluorouracil and Capecitabine, along with the broader Pharmacogenomics effort at UT MD Anderson she has helped to lead! I
ncredibly important work for patient safety. Also, thanks to Gabriel Brooks and Advocates for Universal DPD/DPYD Testing for inspiration over the years.”